Back to Journals » Risk Management and Healthcare Policy » Volume 13

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

Total article views   HTML views PDF downloads Totals
10,138 Dovepress* 9,043+ 1,254 10,297
PubMed Central* 1,095 327 1,422
Totals 10,138 1,581 11,719
*Since 22 January 2020

View citations on PubMed Central and Google Scholar